Matches in Wikidata for { <http://www.wikidata.org/entity/Q36107937> ?p ?o ?g. }
- Q36107937 description "2015 nî lūn-bûn" @default.
- Q36107937 description "2015年の論文" @default.
- Q36107937 description "2015年論文" @default.
- Q36107937 description "2015年論文" @default.
- Q36107937 description "2015年論文" @default.
- Q36107937 description "2015年論文" @default.
- Q36107937 description "2015年論文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015年论文" @default.
- Q36107937 description "2015년 논문" @default.
- Q36107937 description "article científic" @default.
- Q36107937 description "article scientific" @default.
- Q36107937 description "article scientifique (publié 2015)" @default.
- Q36107937 description "articol științific" @default.
- Q36107937 description "articolo scientifico" @default.
- Q36107937 description "artigo científico (publicado na 2015)" @default.
- Q36107937 description "artigo científico (publicado na 2015)" @default.
- Q36107937 description "artigo científico" @default.
- Q36107937 description "artikull shkencor" @default.
- Q36107937 description "artikulong pang-agham" @default.
- Q36107937 description "artykuł naukowy" @default.
- Q36107937 description "artículo científico publicado en 2015" @default.
- Q36107937 description "artículu científicu espublizáu en 2015" @default.
- Q36107937 description "bilimsel makale" @default.
- Q36107937 description "bài báo khoa học" @default.
- Q36107937 description "mokslinis straipsnis" @default.
- Q36107937 description "naučni članak" @default.
- Q36107937 description "scienca artikolo" @default.
- Q36107937 description "scientific article" @default.
- Q36107937 description "teaduslik artikkel" @default.
- Q36107937 description "tieteellinen artikkeli" @default.
- Q36107937 description "tudományos cikk" @default.
- Q36107937 description "vedecký článok" @default.
- Q36107937 description "vetenskaplig artikel" @default.
- Q36107937 description "videnskabelig artikel (udgivet 2015)" @default.
- Q36107937 description "vitenskapelig artikkel" @default.
- Q36107937 description "vitskapeleg artikkel" @default.
- Q36107937 description "vědecký článek" @default.
- Q36107937 description "wetenschappelijk artikel" @default.
- Q36107937 description "wissenschaftlicher Artikel" @default.
- Q36107937 description "επιστημονικό άρθρο" @default.
- Q36107937 description "мақолаи илмӣ" @default.
- Q36107937 description "мақолаи илмӣ" @default.
- Q36107937 description "наукова стаття, опублікована в травні 2015" @default.
- Q36107937 description "научна статия" @default.
- Q36107937 description "научная статья" @default.
- Q36107937 description "научни чланак" @default.
- Q36107937 description "научни чланак" @default.
- Q36107937 description "գիտական հոդված" @default.
- Q36107937 description "מאמר מדעי" @default.
- Q36107937 description "سائنسی مضمون" @default.
- Q36107937 description "مقالة علمية نشرت بتاريخ 27-5-2015" @default.
- Q36107937 description "مقالهٔ علمی" @default.
- Q36107937 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q36107937 description "บทความทางวิทยาศาสตร์" @default.
- Q36107937 description "სამეცნიერო სტატია" @default.
- Q36107937 name "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 name "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 name "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 type Item @default.
- Q36107937 label "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 label "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 label "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 prefLabel "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 prefLabel "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 prefLabel "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 P1433 Q36107937-B297FB56-91B9-4B22-9FDA-71C8E3F496F5 @default.
- Q36107937 P1476 Q36107937-CE8B5AE2-F74D-4815-83EB-08C837FE4504 @default.
- Q36107937 P2093 Q36107937-036A980B-5536-4953-A055-43D751B72A74 @default.
- Q36107937 P2860 Q36107937-259CEAF7-1BAD-499B-9A7B-A135E19CDB40 @default.
- Q36107937 P2860 Q36107937-2BF1C3E4-2024-4F20-9173-548E369AA6E2 @default.
- Q36107937 P2860 Q36107937-4A0C368C-8020-4B55-B1B0-DC5D41FB7013 @default.
- Q36107937 P2860 Q36107937-65842BF5-8D8B-4ECA-8B3B-FCCBF9493F6E @default.
- Q36107937 P2860 Q36107937-74DF08EF-A04D-4BB2-86CD-EA4FFD0A9214 @default.
- Q36107937 P2860 Q36107937-7D0EBDB8-6E8E-4240-AAAA-A76461B6905C @default.
- Q36107937 P2860 Q36107937-7D67CA3E-E1EB-4D93-82C1-54B8F38EFFAA @default.
- Q36107937 P2860 Q36107937-A66DFC46-15DA-4C1C-B757-C1B7F88E7BB5 @default.
- Q36107937 P2860 Q36107937-B5F9401C-54AE-4A00-B727-E70906F95D6E @default.
- Q36107937 P2860 Q36107937-EBD8DFAE-942D-4913-B2C7-B04E920B9525 @default.
- Q36107937 P304 Q36107937-0A8EF227-70CE-417B-97DC-B17B3848AFF9 @default.
- Q36107937 P31 Q36107937-805DF673-C35F-4A36-9662-FA393A3447B6 @default.
- Q36107937 P356 Q36107937-859392B1-4CBD-41F7-84CC-5AF3D1F28EC1 @default.
- Q36107937 P433 Q36107937-0A6050B9-D4F9-43F0-9763-3806ABA5AA4D @default.
- Q36107937 P478 Q36107937-7FE21593-641E-4BA6-9A3C-9F2CB48C59E2 @default.
- Q36107937 P50 Q36107937-509048B1-C447-4E2F-909E-A803282A9DB4 @default.
- Q36107937 P577 Q36107937-0883DD22-FE2F-40F5-8F55-A5DB21744453 @default.
- Q36107937 P698 Q36107937-07310A4D-33DE-4B9F-84DB-C5D832C266AF @default.
- Q36107937 P8608 Q36107937-EB9CD6BB-6CAE-4541-B168-96F6EE63CF1F @default.
- Q36107937 P921 Q36107937-78BBD7CB-CE41-45E3-BFB6-2473A4965B1C @default.
- Q36107937 P921 Q36107937-BAA54986-FA00-4D33-80F7-FCDAC849A84A @default.
- Q36107937 P932 Q36107937-2AA025FA-C992-40B5-AFD1-7923A58CC284 @default.
- Q36107937 P356 2162402X.2015.1029703 @default.
- Q36107937 P698 26451297 @default.
- Q36107937 P1433 Q18026500 @default.
- Q36107937 P1476 "Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future development" @default.
- Q36107937 P2093 "Dan G Duda" @default.